Building the next Biogen

For nearly four decades, our success has been grounded in an enduring commitment to cutting-edge science and the needs of patients. This commitment, coupled with our singular focus on making a meaningful difference in the treatment of disease, will propel us forward as we build the next Biogen.

We have built a successful and growing business by putting science, patients and our employees at the center of every decision and investment we make, and we are proud of the impact our efforts are having. We believe we are well-positioned to leverage advances in biology, genomics and technology as we pursue treatments for some of the most complex diseases.

As we embark on building the Biogen of the future, we will focus on areas with the potential to have the most impact, developing life-changing treatments for people suffering from devastating conditions.

To learn more, please read our 2015 Annual Report on Form 10-K and our 2016 Proxy Statement.

At Biogen, we aspire to have the greatest impact on patients of any biotechnology company in the history of our industry.

— George A. Scangos, Ph.D.
Chief Executive Officer